STOCK TITAN

Senseonics Holdings, Inc. Schedules First Quarter 2021 Earnings Release and Conference Call for May 13, 2021 at 4:30 p.m. Eastern Time

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Senseonics Holdings, Inc. (NYSE-American: SENS) announced plans to release its Q1 2021 financial results after market close on May 13, 2021. A conference call will follow at 4:30 p.m. ET to discuss performance, which will also be available via webcast. Senseonics specializes in implantable continuous glucose monitoring (CGM) systems to aid diabetes management. Their products include the Eversense® and Eversense® XL CGM systems. More details will be accessible on their website.

Positive
  • None.
Negative
  • None.

Senseonics Holdings, Inc. (NYSE-American: SENS), a medical technology company focused on the development and commercialization of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced that it plans to release its first quarter 2021 financial results after market close on Thursday, May 13, 2021.

Management will hold a conference call to review the company’s first quarter 2021 performance starting at 4:30 p.m. (Eastern Time) on the same day. The conference call will be concurrently webcast. The link to the webcast will be available on Senseonics Holdings, Inc. website at www.senseonics.com by navigating to “Investor Relations,” and then “Events & Publications,” and will be archived there for future reference. To listen to the conference call, please dial 1-888-317-6003 (US/Canada) or 1-412-317-6061 (International), passcode 6107459, approximately ten to five minutes prior to start time.

About Senseonics
Senseonics Holdings, Inc. is a medical technology company focused on the design, development and commercialization of transformational glucose monitoring products designed to help people with diabetes confidently live their lives with ease. Senseonics' CGM Systems, Eversense® and Eversense® XL, include a small sensor inserted completely under the skin that communicates with a smart transmitter worn over the sensor. The glucose data are automatically sent every 5 minutes to a mobile app on the user's smartphone.

FAQ

When will Senseonics release its Q1 2021 financial results?

Senseonics will release its Q1 2021 financial results after market close on May 13, 2021.

What time is Senseonics' Q1 2021 conference call?

The conference call to discuss Senseonics' Q1 2021 performance will start at 4:30 p.m. ET on May 13, 2021.

How can I listen to the Senseonics conference call?

You can listen to the conference call by dialing 1-888-317-6003 (US/Canada) or 1-412-317-6061 (International) with passcode 6107459.

What products does Senseonics offer for diabetes management?

Senseonics offers Eversense® and Eversense® XL, which are implantable continuous glucose monitoring systems.

Senseonics Holdings, Inc.

NYSE:SENS

SENS Rankings

SENS Latest News

SENS Stock Data

190.77M
556.26M
6.35%
10.05%
8.05%
Medical Devices
Industrial Instruments for Measurement, Display, and Control
Link
United States of America
GERMANTOWN